Therefore, NRF2 silencing inhibited PPP metabolism and consequently suppressed tumor cell proliferation by restricting purine nucleotides supply [45,49], which implies the beneficial effects of NRF2 inhibition in both normoxic and hypoxic tumor environments. The gene discussed is NFE2L2; the disease is neoplasm.